Finance

Lists
Why is AKUMS down 3,11%?
Dive Deeper
AKUMS:NSE
Akums Drugs and Pharmaceuticals Ltd
₹746,00
-3,11%
(-23,95) 1D
15 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AKUMS...
Open
₹769,95
High
₹769,95
Low
₹743,20
Mkt. cap
114,21 ຕື້
Avg. vol.
287,73 ພັນ
Volume
124,40 ພັນ
Dividend
0,13%
Quarterly dividend
₹0,25
Ex-dividend date
3 ກ.ລ. 2026
P/E ratio
39,16
52-wk high
₹838,80
52-wk low
₹409,30
EPS
₹19,05
No. of employees
7 ພັນ
Open
₹769,95
High
₹769,95
Low
₹743,20
Mkt. cap
114,21 ຕື້
Avg. vol.
287,73 ພັນ
Volume
124,40 ພັນ
Dividend
0,13%
Quarterly dividend
₹0,25
Ex-dividend date
3 ກ.ລ. 2026
P/E ratio
39,16
52-wk high
₹838,80
52-wk low
₹409,30
EPS
₹19,05
No. of employees
7 ພັນ
News stories
From web sources and news partners
The Lufkin Daily News
The Lufkin Daily News
·
55 ນາທີກ່ອນ
Nasdaq reports network disruption, US equities data feeds impacted
marketscreener.com
marketscreener.com
·
22 ນາທີກ່ອນ
Iambic Therapeutics Shares Rise in Nasdaq Debut
24/7 Wall St.
24/7 Wall St.
·
1 ຊົ່ວໂມງກ່ອນ
S&P 500 Flat at Midday While a Rotation Reshapes the Market
Profile
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
About Akums Drugs and Pharmaceuticals Ltd
CEO-
Employees7,34 ພັນ
Founded2004
Headquarters-
SectorHealth care
Websiteakums.in
Last report
10 ສ.ຫ. 2026
Fiscal period
Q1 2027
₹6,53 / ₹6,10
+7,05%beat
Revenue / Est. (INR)
11,67 ຕື້ / 11,65 ຕື້
+0,14%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
10,18 ຕື້
11,60 ຕື້
11,60 ຕື້
11,67 ຕື້
Cost of goods sold
5,93 ຕື້
6,79 ຕື້
7,37 ຕື້
6,45 ຕື້
Cost of revenue
5,93 ຕື້
6,79 ຕື້
7,37 ຕື້
6,45 ຕື້
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 ຕື້
1,89 ຕື້
2,37 ຕື້
2,01 ຕື້
Operating expense
3,68 ຕື້
3,74 ຕື້
3,09 ຕື້
3,88 ຕື້
Total operating expenses
9,61 ຕື້
10,52 ຕື້
10,46 ຕື້
10,33 ຕື້
Operating income
566,12 ລ້ານ
1,07 ຕື້
1,14 ຕື້
1,34 ຕື້
Other non operating income
323,65 ລ້ານ
343,28 ລ້ານ
-942,12 ລ້ານ
303,80 ລ້ານ
EBT including unusual items
656,73 ລ້ານ
995,66 ລ້ານ
1,21 ຕື້
1,39 ຕື້
EBT excluding unusual items
656,73 ລ້ານ
1,18 ຕື້
1,19 ຕື້
1,39 ຕື້
Income tax expense
229,77 ລ້ານ
318,92 ລ້ານ
398,74 ລ້ານ
382,59 ລ້ານ
Effective tax rate
34,99%
32,03%
32,89%
27,48%
Other operating expenses
1,41 ຕື້
1,45 ຕື້
319,86 ລ້ານ
1,45 ຕື້
Net income
407,83 ລ້ານ
663,17 ລ້ານ
846,13 ລ້ານ
1,00 ຕື້
Net profit margin
4,01%
5,72%
7,29%
8,57%
Earnings per share
2,66
5,14
-
6,53
Interest and investment income
-
-
1,10 ຕື້
-
Interest expense
-233,04 ລ້ານ
-237,42 ລ້ານ
-184,41 ລ້ານ
-247,56 ລ້ານ
Net interest expenses
-233,04 ລ້ານ
-237,42 ລ້ານ
912,36 ລ້ານ
-247,56 ລ້ານ
Depreciation and amortization charges
378,64 ລ້ານ
396,49 ລ້ານ
401,18 ລ້ານ
410,65 ລ້ານ
EBITDA
940,04 ລ້ານ
1,42 ຕື້
1,49 ຕື້
1,69 ຕື້
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google